Injected area | V6Ad | MIP | MIP/PE | PEip | |||||
---|---|---|---|---|---|---|---|---|---|
Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
Extrastriate (EXT) | |||||||||
V6 | * | 3.2 | * | 0.6 | 3.4 | 0.9 | * | * | |
Other EXT | 0.9 | * | 2.2 | * | 5.7 | 0.7 | |||
Medial parietal | |||||||||
V6Av | 32.0 | 43.4 | 6.9 | 6.8 | 12.1 | 3.5 | 9.8 | * | * |
V6Ad | # | # | 33.0 | 19.7 | 21.1 | 7.9 | 11.4 | 3.7 | |
PGm | 3.2 | 0.6 | * | 3.1 | * | * | * | * | |
PEci/31 | 3.0 | 4.2 | 3.2 | 11.3 | 7.8 | * | 7.7 | * | |
Superior parietal (SPL) | |||||||||
PE | 0.5 | * | 8.1 | 9.5 | 13.0 | 5.3 | 17.4 | 49.4 | 21.0 |
PEip | * | * | 1.6 | 2.7 | 4.2 | 9.5 | 10.2 | 6.1 | # |
PEc | 22.6 | 3.2 | 31.0 | 15.0 | 13.2 | 3.0 | 2.7 | 10.6 | 6.5 |
Other SPL | * | 0.5 | * | * | 1.4 | * | 3.4 | 28.1 | |
Intraparietal IPS | |||||||||
MIP | 15.7 | 20.0 | # | # | # | # | # | #+ | 5.8 |
VIP | * | 11.2 | * | 4.1 | 4.1 | 12.9 | 11.3 | 1.3 | 9.0 |
LIP | * | * | * | * | 0.8 | 1.2 | * | ||
AIP | * | 1.1 | * | * | * | 4.1 | 1.4 | * | 1.8 |
Inferior parietal (IPL) | |||||||||
Opt/PG | 5.9 | 2.4 | * | * | * | 1.1 | * | * | |
PFG/PF | 1.0 | 3.1 | * | * | * | 2.4 | 0.5 | * | * |
ParOp | * | * | 1.2 | 0.7 | 1.3 | 3.1 | 3.3 | 1.1 | 3.3 |
Temporal | |||||||||
cST | 6.4 | 1.0 | 1.9 | 3.5 | 4.5 | 5.7 | 1.3 | * | * |
Other Temporal | * | * | * | * | * | * | |||
Limbic | |||||||||
23 | 0.8 | 0.5 | * | 1.5 | * | 1.8 | * | * | * |
24 | * | * | * | 3.0 | * | 4.0 | 1.1 | 0.8 | 2.7 |
Rs | * | * | * | * | * | * | * | ||
Motor/premotor | |||||||||
F1 | * | * | 0.9 | 1.3 | 1.1 | 2.3 | 10.0 | 3.9 | 16.6 |
F2 | 5.1 | 3.3 | 6.0 | 10.0 | 5.0 | 19.3 | 16.5 | 9.1 | * |
F3 | * | * | 0.8 | 1.2 | 0.6 | * | 0.9 | 0.9 | 0.6 |
F5/F4 | 0.5 | * | 1.2 | * | 5.2 | 1.0 | * | 1.5 | |
F7 | * | * | * | 1.1 | * | * | * | * | |
F6 | 0.8 | 0.5 | * | 1.0 | * | * | * | * | |
Prefrontal (PrFr) | |||||||||
SEM/FEF | * | * | 2.2 | * | 3.2 | 1.4 | |||
Other PrFr | * | * | * | * | * | * | * | ||
n | 7276 | 19,235 | 4369 | 15,202 | 22,129 | 6808 | 1239 | 2230 | 6457 |
#Location of injection site; *<0.5% of total projections; +, injection site invaded area PE; n, number of extrinsically labeled cells. “Other EXT” includes combined percentages of labeled neurons in V2, Vis, area prostriata, V4, and DP.